Hemab Therapeutics Holdings, Inc. (COAG)

41.45 +1.03 (+2.55%) USD  |  NASDAQ  |  Oct 30, 16:00
41.45 0.00 (0.00%) After-Hours: 20:00
More

Hemab Therapeutics Holdings EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for COAG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (Quarterly YoY Growth) Data

View and export this data back to . Start Trial.
Date Value

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Anixa Biosciences, Inc. Upgrade